We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-2.91%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$134B
AUM Growth
-$18.7B
Cap. Flow
-$13.8B
Cap. Flow %
-10.35%
Top 10 Hldgs %
29.65%
Holding
5,915
New
337
Increased
1,382
Reduced
3,110
Closed
265

Sector Composition

Rank Sector Weight
1 Technology 12.02%
2 Healthcare 5.4%
3 Consumer Discretionary 4.87%
4 Financials 4.64%
5 Industrials 3.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLN icon
2376
Olin
OLN
$2.11B
$1.07M ﹤0.01%
21,337
-1,736
-8% -$93.7K
NBTB icon
2377
NBT Bancorp
NBTB
$2.74B
$1.07M ﹤0.01%
33,629
-20,265
-38% -$694K
TMDV icon
2378
ProShares Russell US Dividend Growers ETF
TMDV
$4.76M
$1.07M ﹤0.01%
24,535
AMLX icon
2379
CALL
Amylyx Pharmaceuticals
AMLX
$2.26B
$1.07M ﹤0.01%
58,200
-2,500
-4% -$52.9K
AMLX icon
2380
PUT
Amylyx Pharmaceuticals
AMLX
$2.26B
$1.07M ﹤0.01%
58,200
-2,500
-4% -$52.9K
MXL icon
2381
MaxLinear
MXL
$6.06B
$1.07M ﹤0.01%
47,881
-61,397
-56% -$1.56M
FROG icon
2382
JFrog
FROG
$9.66B
$1.06M ﹤0.01%
41,993
-8,608
-17% -$239K
FCN icon
2383
FTI Consulting
FCN
$4.4B
$1.06M ﹤0.01%
5,964
-11,087
-65% -$2.07M
NEWR
2384
DELISTED
New Relic, Inc.
NEWR
$1.06M ﹤0.01%
12,421
-3,132
-20% -$252K
GAP
2385
PUT
The Gap Inc
GAP
$7.23B
$1.06M ﹤0.01%
100,000
HASI icon
2386
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.84B
$1.06M ﹤0.01%
50,134
-14,716
-23% -$353K
DNA icon
2387
Ginkgo Bioworks
DNA
$528M
$1.06M ﹤0.01%
14,660
-4,432
-23% -$354K
BOKF icon
2388
BOK Financial
BOKF
$8.58B
$1.06M ﹤0.01%
13,256
-11,764
-47% -$995K
BRBR icon
2389
BellRing Brands
BRBR
$1.44B
$1.06M ﹤0.01%
25,679
-32,056
-56% -$1.23M
PSMT icon
2390
Pricesmart
PSMT
$5.98B
$1.06M ﹤0.01%
14,207
-8,408
-37% -$649K
CRBU icon
2391
Caribou Biosciences
CRBU
$145M
$1.06M ﹤0.01%
221,166
+194,816
+739% +$1.21M
BNL icon
2392
Broadstone Net Lease
BNL
$4.11B
$1.05M ﹤0.01%
73,731
-22,837
-24% -$366K
FCF icon
2393
First Commonwealth Financial
FCF
$2.18B
$1.05M ﹤0.01%
86,222
-59,150
-41% -$779K
VYX icon
2394
NCR Voyix
VYX
$1.14B
$1.05M ﹤0.01%
63,536
-3,227
-5% -$54.9K
GIL icon
2395
Gildan
GIL
$10.3B
$1.05M ﹤0.01%
37,273
-4,171
-10% -$125K
JHG
2396
DELISTED
Janus Henderson
JHG
$1.05M ﹤0.01%
40,621
-15,308
-27% -$419K
TTMI icon
2397
TTM Technologies
TTMI
$12B
$1.05M ﹤0.01%
81,163
-33,965
-30% -$473K
ACHC icon
2398
Acadia Healthcare
ACHC
$2.76B
$1.05M ﹤0.01%
14,866
-1,778
-11% -$133K
NAVI icon
2399
Navient
NAVI
$789M
$1.05M ﹤0.01%
60,698
-102,081
-63% -$1.84M
EEMV icon
2400
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.44B
$1.04M ﹤0.01%
19,577
+13,343
+214% +$732K

Similar funds

Citigroup's Q3 2023 Portfolio in Review

As of Q3 2023, Citigroup held 5,915 positions worth $134B, down 12% from $153B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citigroup withdrew a net $13.8B in Q3 2023, closing 265 positions and reducing 3,110 holdings. Its most notable exit was Magellan Midstream Partners, L.P., an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Citigroup opened a new position in Opera Ltd worth $31.8M.

  • Citigroup's largest Q3 2023 buy was Opera Ltd: 2,825,474 shares worth $31.8M.
  • Citigroup added most to Verisk Analytics in Q3 2023, an estimated $438M increase.
  • Citigroup's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Citigroup fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $121M.
  • Citigroup's ten largest holdings make up 30% of its $134B portfolio in Q3 2023.
  • Citigroup opened 337 new positions and closed 265 in Q3 2023.
  • Citigroup's portfolio value fell 12% quarter-over-quarter to $134B.

Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.